ASCRS 2024: 10-year results from a real-world study shed new light on glaucoma


At ASCRS in Boston, Paul Harasymowycz, MD shared a decade's worth of data on MIGS procedures for primary open-angle glaucoma

At this year's ASCRS meeting in Boston, Massachusetts, we caught up with Paul Harasymowycz, MD, who detailed his presentation "Decade-Long Outcomes of Two First-Generation Trabecular Micro-Bypass Stents with Cataract Surgery in Primary Open-Angle Glaucoma." Here, he shares the highlights from a decade's worth of data.

Editor's note: The below transcript has been lightly edited for clarity.

Hello, I'm Dr Paul Harasymowycz, from University of Montreal and McGill University. Today we have the pleasure of presenting our 10-year results of using two [first-generation trabecular micro bypass] iStents with cataract surgery. So that's a decade of results using MIGS surgery. I think that's a very important contribution to our knowledge.

This was a real world study. In the end, we had 56 patients that we followed over time. The most important is that they had OCT stability up until 10 years. The average pressure before was higher than 18. And even after 10 years, a decade, their pressure was almost at 14. That's very important. Another finding in our study was that 75% of our patients, their pressure was below 15. And we know, usually, the lower we keep the pressure, the less likelihood is that their glaucoma will progress. And so I think that's great for our patients. In the end, it's all about the patients. And the study does show that using angle surgery may be beneficial to your patients as well.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.